 BOSTON, March 01, 2022 GLOBE NEWSWIRE -- Inozyme Pharma, Inc. Nasdaq: INZY, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced Axel Bolte, MSc, MBA, the companys co-founder, president, and chief executive officer, will participate in a fireside chat at the Cowen 42nd Annual Health Care Conference on Tuesday, March 8th at 11:10 AM ET. 